Pholcodine in cough medicines and IgE-sensitization in the EU: An urgent task

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 5, 2012, Pages 581-582

  Florvaag, E ^a,b   Johansson, S G O ^c,d  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; NEUROMUSCULAR BLOCKING AGENT; OMALIZUMAB; PHOLCODINE; SUXAMETHONIUM;

ALLERGIC REACTION; ANAPHYLAXIS; ANTIBODY PRODUCTION; ASTHMA; BONE MARROW TRANSPLANTATION; COUGHING; EUROPEAN UNION; GRAFT VERSUS HOST REACTION; HUMAN; NOTE; PRIORITY JOURNAL; SENSITIZATION;

ANAPHYLAXIS; ANTITUSSIVE AGENTS; CODEINE; COUGH; EUROPEAN UNION; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOGLOBULIN E; MORPHOLINES;

EID: 84859745050     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02803.x     Document Type: Note

References (13)

1. Florvaag E, Johansson SGO, Öman H, Harboe T, Nopp A. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study. Allergy 2006;61:49-55. (Pubitemid 43381191)
2. Harboe T, Johansson SGO, Florvaag E, Öman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 2007;62:1445-1450. (Pubitemid 350045601)
3. Ringdén O, Persson U, Johansson SGO. Are increased IgE-levels a signal of an acute graft-versus-host reaction? Immunol Rev 1983;71:57-75. (Pubitemid 13007964)
4. Florvaag E, Johansson SGO, Öman H, Venemalm L, Degerbeck F, Dybendal T et al.Prevalence of IgE antibodies to morphine. Relation to the high and low incidence of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005;49:437-444. (Pubitemid 40488565)
5. Harboe T, Guttormsen AB, Irgens Å, Dybendal T, Florvaag E. Anaphylaxis during anaesthesia in Norway. A six-year single centre study. Anesthesiology 2005;102:897-903.
6. Florvaag E, Johansson SG, Irgens Å, de Pater GH. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011;66:955-960.
7. Pestel J, Dessaint JP, Joseph M, Bazin H, Capron A. Macrophage triggering by aggregated immunoglobulins. II. Comparison of IgE and IgG aggregates or immune complexes. Clin Exp Immunol 1984;57:404-412. (Pubitemid 14089390)
8. Smith-Norowitz TA, Wong D, Kusonruksa M, Norowitz KB, Joks R, Durhin HG et al. Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine. Int J Med Sci 2011;8:239-244.
9. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M et al. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 2008;63:1255-1266.
10. Johansson SGO, Öman H, Nopp A, Florvaag E. Pholcodine caused anaphylaxis in Sweden 30-years ago. Allergy 2009;64:820-821.
11. Krøigaard M, Garvey LH, Menne T, Husum B. Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing? Br J Anaesth 2005;95:468-471. (Pubitemid 41418740)
12. Currie M, Webb RK, Williamson JA, et al. The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 1993;21:621-625. (Pubitemid 23311294)
13. Bonini S. An allergist is the new Executive Director of the European Medicine Agency. Allergy 2012;67:3.